To see all protocols that comply with the WHO Essential Medicine List 

Early stage Hodgkin lymphoma (stage l and ll) is divided into favourable and unfavourable characteristics. The tables below indicate the variations in criteria for defining risk groups according to the various trial groups.

Table 1r

Risk stratification of early-stage Hodgkin lymphoma, by research group

© The Lancet 2012

Table 2 r

© NEJM 2010

While every effort has been made to ensure the accuracy of the content at the time of publication, the Cancer Institute NSW does not accept any liability, with respect to loss, damage, injury or expense arising from any such errors or omission in the contents of this work. Any reference to specific pharmaceuticals and/or medical products as examples does not imply endorsement of any of these products. Use is subject to eviQ’s disclaimer available at

Send feedback for this page

Last reviewed:
Review due:

The currency of this information is guaranteed only up until the date of printing, for any updates please check:

21 Aug 2019